Search

everythinglearnresearchcommunity

for

Search:↓

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

A post-COVID-19 patient in Manaus developed cryptococcal meningitis, highlighting the need for better health education and sanitation.

5% topical minoxidil improves hair density and quality in monilethrix patients.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Monocytes might be linked to hair loss after COVID-19.

Complete COVID-19 vaccination reduces the risk of long COVID.

COVID-19 increases the risk of hair loss, but vaccination can reduce this risk.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 can cause temporary hair loss due to stress and inflammation.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 may trigger systemic lupus erythematosus in some people.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

During COVID-19, Iraqi women saw more hair loss and skin issues like acne due to stress, masks, and hygiene habits.

During the COVID-19 pandemic in China, skin conditions like eczema and warts increased among children, while respiratory-transmitted skin infections decreased, partly due to mask-wearing.

A variant in the KRT31 gene causes a rare hereditary hair disorder called monilethrix.

Long COVID causes lasting symptoms and needs ongoing care.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

COVID-19 can cause skin problems.